Fertility-focused Kindbody provides genetic testing with Phosphorus Labs acquisition

Fertility firm Kindbody introduced Tuesday it’s going to carry genetic testing in-house with the acquisition of Phosphorus Labs.

The deal will present Kindbody with a reference lab in Secaucus, N.J., in addition to Phosphorus’ employees of geneticists and lab technicians, who will be part of the fertility startup’s new KindLabs division.

This acquisition marks Kindbody’s second in 2022. In February, the corporate introduced it had entered into an settlement to purchase Vios Fertility Institute, a community of fertility clinics.

“I am excited to welcome the Phosphorus group to the Kindbody household. With KindLabs, our sufferers will expertise a seamless integration of high-quality genetic testing providers,” Dr. Dean Morbeck, chief scientific officer at Kindbody, stated in an announcement.

“Along with offering a possibility to carry current diagnostic testing in-house, KindLabs allows us to additional our mission to regulate prices and enhance affected person expertise and outcomes by growing and integrating new diagnostic options.”


Kindbody stated it’s going to start doing its personal genetic testing later this 12 months. Earlier than the acquisition, the corporate had outsourced preimplantation genetic testing for aneuploidy — screening embryos for further or lacking chromosomes throughout IVF — and expanded service screening for genes that might trigger issues.

“This acquisition permits us to include genomics into our on a regular basis affected person care, serving to Kindbody construct wholesome households now and sooner or later. I’m very joyful to welcome the group to KindLabs and am honored to work alongside this proficient group,” Kindbody Chief Genomics Officer Dr. Amber Cooper stated in an announcement. 


Earlier this 12 months, Kindbody launched a line of at-home fertility hormone checks for women and men. The fertility startup raised $62 million in Sequence C funding a few 12 months in the past and $32 million in Sequence B financing in 2020.

Different corporations within the fertility house embrace male-focused startup Legacy, which lately raised $25 million; direct-to-consumer digital care firm Ro, which has acquired each Dadi and Fashionable Fertility; and Proov, which raised $9.7 million late final 12 months.  

Ladies’s hybrid supplier Tia lately introduced an growth into fertility providers, together with fertility testing, counseling and care planning, in addition to consultations for pregnant sufferers about their choices.

Supply hyperlink

What's your reaction?

In Love
Not Sure

You may also like

More in:Health

Leave a reply

Your email address will not be published. Required fields are marked *